All In Biotech

Company · ABBV

AbbVie

Includes drugs filed under related and acquired sponsor names. Trials are searched under: AbbVie; Allergan; Pharmacyclics LLC..

Last checked: Nov 19, 2026Source: Drugs@FDA, ClinicalTrials.gov

NDAs and BLAs

198

83 still marketed

Novel approvals

62

Approvals since 2021

78

Originals and new uses

Phase 3 trials

458

Registered, any status

Trials by phase

All registered drug and biologic trials with this lead sponsor, any status. A public view of the pipeline.

Recent approvals

Originals and efficacy supplements, newest first.

  • Skyrizi new use Priority reviewOrphanOct 23, 2026
  • Juvmo approved NovelSep 25, 2026
  • Skyrizi new use OrphanJun 26, 2026
  • Skyrizi new use OrphanJun 12, 2026
  • Decnupaz approved NovelPriority reviewOrphanMay 27, 2026
  • Linzess new use Priority reviewMay 21, 2026
  • Venclexta new use OrphanMay 20, 2026
  • Skyrizi new use OrphanMar 6, 2026
  • Venclexta new use OrphanFeb 19, 2026
  • Vraylar new use Priority reviewDec 18, 2025

Drugs in development (36)

Investigational drugs, not yet FDA-approved, in this company's active or recent Phase 2 and 3 trials. Phase 3 first.

Open in pipeline
  • Telisotuzumab AdizutecanABBV-400Phase 316 trials

    AbbVie · c-MET, Non-Squamous Non-Small Cell Lung Cancer, Metastatic Colorectal Cancer

  • EtentamigABBV-383, TNB-383BPhase 38 trials

    AbbVie · Multiple Myeloma, Relapsed or Refractory Multiple Myeloma, Amyloid Light Chain (AL) Amyloidosis

  • LutikizumabABT-981Phase 38 trials

    AbbVie · Hidradenitis Suppurativa, Atopic Dermatitis, Rheumatoid Arthritis

  • BMS-986348CC-92480, mezigdomidePhase 37 trials

    Bristol Myers Squibb · Multiple Myeloma, Relapsed or Refractory Multiple Myeloma

  • BudigalimabABBV-181Phase 36 trials

    AbbVie · Hepatocellular Carcinoma, Non Small Cell Lung Carcinoma, c-MET

  • ABBV-706Phase 34 trials

    AbbVie · Small Cell Lung Cancer, Extensive Stage-Small Cell Lung Cancer (ES-SCLC), Extensive Stage-Small Cell Lung Cancer

  • AmrubicinJapan onlyPhase 34 trials

    Gilead Sciences · Small Cell Lung Cancer, Extensive Stage Small Cell Lung Cancer (ES-SCLC), Small Cell Lung Cancer (SCLC)

  • folinic acidPhase 34 trials

    Astellas · Unresectable Metastatic Colorectal Cancer, Locally Advanced Unresectable Gastroesophageal Junction (GEJ) Adenocarcinoma or Cancer, Locally Advanced Unresectable Gastric Adenocarcinoma or Cancer

  • LivmoniplimabABBV-151Phase 34 trials

    AbbVie · Hepatocellular Carcinoma, Urothelial Carcinoma, Non-Small Cell Lung Cancer

  • ABBV-722Phase 32 trials

    AbbVie · Rheumatoid Arthritis, Systemic Sclerosis

  • AGN-151586Phase 32 trials

    AbbVie · Forehead Lines, Glabellar Lines

  • Surabgene LomparvovecABBV-RGX-314Phase 32 trials

    AbbVie · Diabetic Retinopathy, Neovascular Age-related Macular Degeneration

  • ABBV-1480Phase 31 trial

    AbbVie · Non-Small Cell Lung Cancer

  • ABBV-444Phase 31 trial

    AbbVie · Dry Eye Disease

  • ABBV-932Phase 23 trials

    AbbVie · Bipolar I or II Disorder, Generalized Anxiety Disorder (GAD), Bipolar I Disorder

  • ABBV-295Phase 22 trials

    AbbVie · Obesity, Overweight, Moderate to Severe Psoriasis

  • ABBV-701Phase 22 trials

    AbbVie · Crohn's Disease, Ulcerative Colitis, Psoriatic Arthritis

  • AGN-151607-DPPhase 22 trials

    AbbVie · Ventral Hernia, Upper Limb Essential Tremor

  • BRIMOCHOL PF eye dropsCARBACHOL PF eye drops, Brimonidine tartrate eye dropsPhase 22 trials

    Zhaoke (Guangzhou) Ophthalmology Pharmaceutical Ltd. · Presbyopia, Recurrent Ovarian Cancer, Folate Receptor-Alpha Positive

  • IcalcaprantABBV-1354, CVL-354Phase 22 trials

    AbbVie · Bipolar I Disorder, Bipolar II Disorder, Major Depressive Disorder

  • IMGN632Phase 22 trials

    AbbVie · Blastic Plasmacytoid Dendritic Cell Neoplasm, Myeloproliferative Neoplasm, Acute Myeloid Leukemia

  • TrosunilimabABBV-382Phase 22 trials

    AbbVie · Crohn's Disease, Ulcerative Colitis

  • ABBV-142Phase 21 trial

    AbbVie · Idiopathic Pulmonary Fibrosis

  • ABBV-1758Phase 21 trial

    AbbVie · Alzheimer's Disease

  • ABBV-2001Phase 21 trial

    AbbVie · Multiple Myeloma

Recruiting Phase 3 trials

Largest first.

Marketed drugs (83)

Newest FDA action first.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.